Innovus Pharmaceuticals Inc - La Jolla, California 92037

Innovus Pharmaceuticals Inc is categorized under in La Jolla, CA .

Business Name: Innovus Pharmaceuticals Inc
Contact Person: Bassam Damaj
Address: 4275 Executive Square # 200, La Jolla, California 92037
Phone Number: (858) 964-5123
Website Address: innovuspharma.com
Annual Revenue (USD): $0 to $49.999
Founding Year: 1959
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Auspex Pharmaceuticals Inc - La Jolla, CA 92037
Merck & CO Inc - La Jolla, CA 92037
Sova Pharmaceuticals Inc - La Jolla, CA 92037
Neuro Map LLC - La Jolla, CA 92037
Cebix Inc - La Jolla, CA 92037
Transdel Pharmaceuticals Inc - La Jolla, CA 92037
Anaborex Inc - La Jolla, CA 92037
Chemokine Pharmaceutical Inc - La Jolla, CA 92037
Metabasis Therapeutics Inc - La Jolla, CA 92037
Sanrx Pharmaceuticals, Inc - La Jolla, CA 92037
Ligand Pharmaceuticals Inc - La Jolla, CA 92037
Kuck Julie MD - La Jolla, CA 92037
Orexigen Therapeutics Inc - La Jolla, CA 92037
Kanisa Pharmaceuticals Inc - La Jolla, CA 92037
Kyowa Hakko Kirin California - La Jolla, CA 92037
Columbia U S A - La Jolla, CA 92037
Singularis Inc - La Jolla, CA 92037

The company Innovus Pharmaceuticals Inc provides BOTH services in the form of from its headquarters in California. 1 to 4 employees work for Innovus Pharmaceuticals Inc, and the business now earns $0 to $49.999 per annum.

Innovus Pharmaceuticals Inc was launched in 1959 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Innovus Pharmaceuticals Inc, please call Bassam Damaj with the phone number (858) 964-5123 or visit its headquarters at 4275 Executive Square # 200 in La Jolla, California 92037.

The location of the headquarters can also be found using the coordinates 32.873933,-117.215061. Read more details about this business on the webpage innovuspharma.com or follow the company’s social media accounts, on Twitter and on Facebook.